Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Multimeric-001 in Healthy Volunteers
NCT00877448Phase 2Completed
- Sponsor
- Scinai Immunotherapeutics Ltd.
- Start
- Jun 2009
- Primary completion
- Oct 2009
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of multimeric-001 in influenza, sponsored by Scinai Immunotherapeutics Ltd.. Started Jun 2009; status: completed.
02
Drugs
multimeric-001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00877448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877448.